Free Trial

LivaNova (NASDAQ:LIVN) Price Target Raised to $120.00

LivaNova logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Barclays raised its LivaNova price target to $120 from $105 and maintained an “overweight” rating, implying 31.36% upside from the stock’s then-current price.
  • Analyst sentiment was broadly positive: nine analysts rated the stock Buy and three Hold, for a “Moderate Buy” consensus and an average target of $101.22.
  • LivaNova reported quarterly EPS of $1.23, beating the $1.06 estimate, while revenue of $393.15 million topped expectations and grew 9.9% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

LivaNova (NASDAQ:LIVN - Get Free Report) had its price objective upped by equities research analysts at Barclays from $105.00 to $120.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has an "overweight" rating on the stock. Barclays's price objective would suggest a potential upside of 31.36% from the stock's current price.

Several other brokerages have also recently issued reports on LIVN. Stifel Nicolaus set a $85.00 target price on shares of LivaNova in a report on Wednesday, August 5th. Piper Sandler reaffirmed an "overweight" rating and issued a $90.00 target price (up from $87.00) on shares of LivaNova in a research report on Wednesday, September 2nd. Jefferies Financial Group reiterated a "buy" rating on shares of LivaNova in a research note on Wednesday. Zacks Research cut LivaNova from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 19th. Finally, Robert W. Baird increased their price target on LivaNova from $95.00 to $111.00 and gave the company an "outperform" rating in a report on Thursday. Nine analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, LivaNova currently has a consensus rating of "Moderate Buy" and an average price target of $101.22.

Read Our Latest Research Report on LivaNova

LivaNova Stock Performance

NASDAQ:LIVN traded up $1.36 during mid-day trading on Monday, reaching $91.36. The company's stock had a trading volume of 51,574 shares, compared to its average volume of 742,800. LivaNova has a 12-month low of $49.83 and a 12-month high of $99.38. The firm's fifty day moving average price is $79.27 and its two-hundred day moving average price is $73.54. The company has a current ratio of 1.46, a quick ratio of 1.22 and a debt-to-equity ratio of 0.22. The stock has a market cap of $5.03 billion, a P/E ratio of 30.42 and a beta of 0.91.

LivaNova (NASDAQ:LIVN - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.17. The business had revenue of $393.15 million for the quarter, compared to analysts' expectations of $381.13 million. LivaNova had a net margin of 13.01% and a return on equity of 16.10%. The business's revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.11 EPS. On average, equities analysts forecast that LivaNova will post 3.79 EPS for the current fiscal year.

Insider Activity at LivaNova

In other news, Director Brooke Story sold 2,300 shares of LivaNova stock in a transaction on Friday, September 4th. The shares were sold at an average price of $81.42, for a total transaction of $187,266.00. Following the transaction, the director owned 7,488 shares in the company, valued at $609,672.96. This trade represents a 23.50% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Francesco Bianchi sold 3,500 shares of LivaNova stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $78.01, for a total transaction of $273,035.00. Following the transaction, the director owned 4,434 shares in the company, valued at $345,896.34. This represents a 44.11% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 7,450 shares of company stock worth $591,839 over the last quarter. Insiders own 0.35% of the company's stock.

Institutional Trading of LivaNova

Hedge funds have recently bought and sold shares of the stock. Allworth Financial LP boosted its holdings in LivaNova by 93.5% in the 2nd quarter. Allworth Financial LP now owns 298 shares of the company's stock worth $25,000 after buying an additional 144 shares during the period. Root Financial Partners LLC purchased a new stake in LivaNova in the 3rd quarter worth $32,000. Farther Finance Advisors LLC increased its stake in LivaNova by 59.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 452 shares of the company's stock worth $35,000 after buying an additional 169 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in LivaNova during the second quarter valued at about $37,000. Finally, Sterling Capital Management LLC raised its holdings in LivaNova by 34.6% during the third quarter. Sterling Capital Management LLC now owns 1,261 shares of the company's stock valued at $96,000 after acquiring an additional 324 shares during the period. Institutional investors own 97.64% of the company's stock.

LivaNova Company Profile

(Get Free Report)

See Also

Analyst Recommendations for LivaNova (NASDAQ:LIVN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in LivaNova Right Now?

Before you consider LivaNova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LivaNova wasn't on the list.

While LivaNova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines